海吉亞醫療控股有限公司（06078）于2025年12月23日发布翌日披露报表。公告显示，公司当日于香港联交所回购238,800股普通股股份，占此前已发行股本约0.0386%。本次回购价格介乎每股12.50港元至12.62港元，总金额约2,999,278港元。
\n\n回购完成后，公司已发行股本由617,963,400股降至617,724,600股，库藏股数量增至774,400股，已发行股份总数维持在618,499,000股。公司于2025年6月27日通过的股份回购授权规模为61,849,900股，至今已累计回购774,400股，占授权数量约0.1252%。
\n\n公告称，此次回购经董事会正式授权，并已遵守香港联交所证券上市规则及相关法律法规要求。上述信息由公司执行董事任爱签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.